Addressing the adherence challenge in tuberculosis treatment: more than digital technologies
- PMID: 37061297
- DOI: 10.1016/S2214-109X(23)00160-2
Addressing the adherence challenge in tuberculosis treatment: more than digital technologies
Conflict of interest statement
I declare no competing interests.
Comment on
-
Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomised superiority trial.Lancet Glob Health. 2023 May;11(5):e693-e703. doi: 10.1016/S2214-109X(23)00068-2. Lancet Glob Health. 2023. PMID: 37061308 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical